| Ms Elizabeth P O'connor, CRNA | |
|
1925 Glenn Mitchell Drive, Suite 102, Gastroenterology Consultants, Virginia Beach, VA 23456 | |
| (757) 464-1644 | |
| (703) 563-6256 |
| Full Name | Ms Elizabeth P O'connor |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 43 Years |
| Location | 1925 Glenn Mitchell Drive, Suite 102, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104849652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | NA2725 (California) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 0024147143 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Digestive Care Llc | 3870669419 | 196 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Entity Name | North American Partners In Anesthesia (virginia), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922031442 PECOS PAC ID: 9931192739 Enrollment ID: O20041217000009 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Entity Name | Greensboro Anesthesia Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073772612 PECOS PAC ID: 8729129226 Enrollment ID: O20100106000273 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Entity Name | California Anesthesia Network Nursing Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699067371 PECOS PAC ID: 0547447732 Enrollment ID: O20120418000094 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Entity Name | Gastroenterology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902862071 PECOS PAC ID: 6608113956 Enrollment ID: O20190124003452 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Entity Name | Capital Digestive Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992752521 PECOS PAC ID: 3870669419 Enrollment ID: O20211124000446 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Elizabeth P O'connor, CRNA 11781 Lee Jackson Memorial Hwy, Suite 550, Fairfax, VA 22033-3309 Ph: (571) 777-5102 | Ms Elizabeth P O'connor, CRNA 1925 Glenn Mitchell Drive, Suite 102, Gastroenterology Consultants, Virginia Beach, VA 23456 Ph: (757) 464-1644 |
News Archive
A new method for fighting skin wrinkles has been developed at the Hebrew University Faculty of Agriculture, Food and Environmental Quality Sciences.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.
An international team of scientists, led by researchers at the University of Cyprus and University of California San Diego School of Medicine, have identified a previously unknown, large-scale association between molecular gene expression activity in blood leukocyte cells and altered neural responses to speech in toddlers with autism as measured with functional magnetic resonance imaging (fMRI).
› Verified 5 days ago
Mary Sharon Clements, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0055 | |
Anne Dunham Rudolph, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2540 Penshurst Way, Virginia Beach, VA 23456 Phone: 757-427-1099 | |
Ms. Luree S Holt, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 465 N Great Neck Rd, Virginia Beach, VA 23454 Phone: 757-625-6873 | |
Heidi Lerner, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-8369 | |
Susan Murrell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2025 Glenn Mitchell Dr, Virginia Beach, VA 23456 Phone: 757-507-1000 | |
Mrs. Bonita Keaveny Doyle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 134 Business Park Dr, Virginia Beach, VA 23462 Phone: 757-473-0055 |